FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE183.250.25 (+0.14 %)
PREV CLOSE ( ) 183.00
OPEN PRICE ( ) 184.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11408
TODAY'S LOW / HIGH ( )181.00 186.05
52 WK LOW / HIGH ( ) 132.3214
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax-518.74269.43516.31434.201287.06
Adjustment1201.55431.85396.10340.10310.54
Changes In working Capital449.27-173.78-151.22-290.26-365.59
Cash Flow after changes in Working Capital1132.09527.50761.19484.041232.00
Cash Flow from Operating Activities1166.95434.41625.97344.60903.42
Cash Flow from Investing Activities-563.20-260.38-415.50-436.59-965.80
Cash Flow from Financing Activities-407.86-215.78-11.43-474.47122.23
Net Cash Inflow / Outflow195.89-41.75199.04-566.4759.86
Opening Cash & Cash Equivalents-18.8422.91-182.24384.23324.37
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANA6.12NANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent177.06-18.8422.91-182.24384.23

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.